fashion -WSS

fashion

author：entertainment 2025-10-01 14:19:53 - browse：9213

Travere Therapeutics said Thursday that a study meant to confirm the benefit of its newly approved drug for a rare kidney disorder narrowly failed.

In the trial, 404 patients with the disorder, IgA nephropathy, were randomized to receive either Travere’s daily pill, Filspari, or irbesartan, a decades-old blood pressure drug often used to help manage the disease. Early data had showed the drug cut protein levels in the urine, a biomarker of kidney function, by half after nine months. That convinced regulators to give Filspari accelerated approval in February, pending full results using a more direct measure of kidney function.

The new data, after 24 months, showed that patients who received Filspari declined less quickly than those in the control group. But the results just missed statistical significance, with a P value of 0.058.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Laying a path for careers in science

WSS

Medicare isn't yet testing food as medicine

Children’s Hospital revives plan for pedestrian bridge

Medicare isn't yet testing food as medicine

Idaho abortion case may prompt more restrictions in other states

How I ended up pumping milk in a bathroom stall at JPM 2024

Idaho abortion case may prompt more restrictions in other states

knowledge

fashion

leisure time

The high cost of giving birth even with insurance

HHS names first

DIEP, the 'gold standard' of breast reconstruction, is under threat

New Medicare drug pricing powers could soon be upended in court

Medicare proposal to cover medical devices draws a mixed reaction

CDC panel: People 65 and older should get a Covid spring booster shot

Duchenne breakthrough therapy leaves behind pioneering families

New England Journal of Medicine addresses racist history, slavery

In age of alternative facts, a scholarly course on calling out crap

Fauci’s Covid grilling leads GOP to weigh foreign research rules

hotspot

Are embryos people? Reproductive medicine's future depends on the answer

Childhood vaccination ad campaign launches in the U.K.

Readout Newsletter: Beam, Prozac, "TechBio" and more

Neuroscience renaissance leads to new crop of psychiatric drugs

Risky weight loss products often used by teens globally, per study

Virtual repurposing can help discover new uses for existing drugs

Wikipedia

knowledge

hotspot

leisure time